Dimethyl fumarate-induced changes in the MS lymphocyte repertoire: No need for subset monitoring

Affiliations

¹ From the Department of Neurology (J.K.), Amsterdam UMC, Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, the Netherlands; and Department of Neurology (A.T.R.), University of Chicago, IL. j.killestein@vumc.nl.
² From the Department of Neurology (J.K.), Amsterdam UMC, Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, the Netherlands; and Department of Neurology (A.T.R.), University of Chicago, IL.

Editorial

Joep Killestein et al. Neurology. 2019.

. 2019 Apr 9;92(15):696-697.

doi: 10.1212/WNL.0000000000007255. Epub 2019 Mar 27.

¹ From the Department of Neurology (J.K.), Amsterdam UMC, Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, the Netherlands; and Department of Neurology (A.T.R.), University of Chicago, IL. j.killestein@vumc.nl.
² From the Department of Neurology (J.K.), Amsterdam UMC, Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, the Netherlands; and Department of Neurology (A.T.R.), University of Chicago, IL.

No abstract available

Comment on

Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice.
Mehta D, Miller C, Arnold DL, Bame E, Bar-Or A, Gold R, Hanna J, Kappos L, Liu S, Matta A, Phillips JT, Robertson D, von Hehn CA, Campbell J, Spach K, Yang L, Fox RJ. Mehta D, et al. Neurology. 2019 Apr 9;92(15):e1724-e1738. doi: 10.1212/WNL.0000000000007262. Epub 2019 Mar 27. Neurology. 2019. PMID: 30918100 Free PMC article.